Patent · US Active

Anti-HPV E7 antibodies

US9902763B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignees

OSTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN · AT
AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MBH · AT

Inventors

Pidder Jansen-Durr · Innsbruck, AT
Werner Zwerschke · Innsbruck, AT
Haymo Pircher · Zirl, AT
Daniela Ehehalt · Innsbruck, AT
Barbara Lener · Innsbruck, AT
Kerstin Dreier · Innsbruck, AT

Key dates

Filing date	Jan 6, 2016
Grant date	Feb 27, 2018
Priority date	—
Expiry date	Jan 6, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to monoclonal anti-HPV (human papillomavirus) E7 antibodies capable of specifically recognizing an epitope of the C-terminal or the N-terminal region of a HPV E7 protein, diagnostic compositions and kits comprising said antibodies as well as methods for immunohistochemical and ELISA-based diagnosis of HPV infections utilizing said antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.